Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 13/20 | 0.77 |
| ▸ | PGR | P06401 | 5/20 | 0.77 |
| ▸ | AR | P10275 | 5/20 | 0.77 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.77 |
| ▸ | CNR1 | P21554 | 1/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13928701 | 1.00 | NR3C1 (0.77) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL15226108 | 0.95 | NR3C1 (0.81) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL15226064 | 0.95 | NR3C1 (0.74) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL4214715 | 0.95 | NR3C1 (0.76) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL15225616 | 0.94 | NR3C1 (0.74) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL4216147 | 0.94 | NR3C1 (0.74) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL15225820 | 0.94 | NR3C1 (0.75) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL4220984 | 0.94 | NR3C1 (0.77) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL4214725 | 0.94 | NR3C1 (0.77) | NR3C1PGRARNR3C2CNR1 | |
| SCHEMBL15226031 | 0.94 | NR3C1 (0.77) | NR3C1PGRARNR3C2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8785425-B2 | 11β-hydroxyandrosta-4-ene-3-ones | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. | 2014-07-22 | — | — | US | claimed |
| EP-2004667-B1 | NOVEL 11 BETA - HYDROXYANDROSTA-4-ENE-3-ONES | SUN PHARMA ADVANCED RES CO LTD (IN) | 2013-09-04 | — | — | EP | claimed |
| US-20090054388-A1 | NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES | SUN PHARMA ADVANCE RESEARCH COMPANY (IN) | 2009-02-26 | — | — | US | claimed |
| US-8785425-B2 | 11β-hydroxyandrosta-4-ene-3-ones | SUN PHARMA ADVANCED RESEARCH COMPANY LTD. | 2014-07-22 | — | — | US | disclosed |
| EP-2004667-B1 | NOVEL 11 BETA - HYDROXYANDROSTA-4-ENE-3-ONES | SUN PHARMA ADVANCED RES CO LTD (IN) | 2013-09-04 | — | — | EP | disclosed |
| US-20090281301-A1 | Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate | DONG-A-PHARM.CO LTD (KR) | 2009-11-12 | — | — | US | disclosed |
| US-20090054388-A1 | NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES | SUN PHARMA ADVANCE RESEARCH COMPANY (IN) | 2009-02-26 | — | — | US | disclosed |
| EP-0523110-A1 | NUCLEOSIDE DERIVATIVES | NYCOMED IMAGING AS (NO) | 1993-01-20 | — | — | EP | disclosed |
| WO-1991015498-A2 | NUCLEOSIDE DERIVATIVES | NYCOMED IMAGING AS (NO) | 1991-10-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054388-A1 | NOVEL 11 BETA-HYDROXYANDROSTA-4-ENE-3-ONES | HSD11B1, HSD3B1, HSD3B2 | NR3C1 37/4885PGR 146/4885AR 22/4885 |
| US-20090281301-A1 | Manufacturing Process of 2' ,2' - Difluoronucleoside and Intermediate | DERA, ALDOA, ENY2 | NR3C1 3640/4885PGR 4873/4885AR 2334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.